Rare diseases
Investigational molecules
Locations
Back to France1 156 clinical trials in Bordeaux, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)A Study of GEN1047 in Patients with Solid Tumors: First Time Use in Humans
FranceStudy of Long-term Safety of Tazemetostat in Patients Who Previously Participated in Tazemetostat Clinical Trials
FranceStudy on the Safety and Effects of YTB323, Fludarabine Phosphate, and Tocilizumab in Patients with Severe, Refractory Systemic Lupus Erythematosus
FranceStudy on Glenzocimab for Patients with Large Ischemic Stroke Eligible for Endovascular Therapy
FranceStudy of Raludotatug Deruxtecan for Patients with Platinum-resistant High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
FranceStudy of Gilteritinib and Chemotherapy for Children, Adolescents, and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia with FLT3 Mutation
FranceStudy of mRNA-4157 and Pembrolizumab for Patients with Resectable Locally Advanced Cutaneous Squamous Cell Carcinoma
FranceStudy of Acalabrutinib for Patients with Chronic Lymphocytic Leukemia
FranceStudy of Zanubrutinib and Rituximab Compared to Bendamustine and Rituximab for Patients with Untreated Mantle Cell Lymphoma Ineligible for Stem Cell Transplant
FranceStudy on the Dose and Safety of Asciminib in Children with Chronic Myeloid Leukemia
FranceStudy of MK-2870 for Patients with Advanced or Metastatic Stomach Cancer, Comparing Its Effects to a Drug Combination
FranceFranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on psoriatic arthritis and hidradenitis suppurativa, evaluating new therapeutic combinations and treatment strategies. Studies explore the effectiveness of targeted therapies and novel approaches like fecal microbiota transplantation.
Clinical trials aim to improve patient outcomes through combination therapies and innovative treatment approaches.
Comprehensive studies investigating treatments for various cancers, including head and neck squamous cell carcinoma, endometrial cancer, and bladder cancer. Research focuses on immunotherapy combinations and targeted treatments.
Trials evaluate novel drug combinations and therapeutic approaches for better cancer treatment outcomes.
Ground-breaking research in kidney transplantation, focusing on preventing rejection and improving long-term outcomes. Studies evaluate new immunosuppressive strategies and antibody-mediated rejection treatments.
Research aims to enhance transplant success rates and patient quality of life.
Studies examining multiple sclerosis, narcolepsy, and major depressive disorder. Research investigates neuroinflammation patterns and innovative treatment approaches.
Trials focus on understanding disease mechanisms and developing targeted therapies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
